Does Molina Healthcare Cover Viagra?

How Erectile Dysfunction Drug Coverage Works Under Medicaid

Medicaid does not require states to cover erectile dysfunction medications. Federal Medicaid law establishes "optional" drug categories, and ED drugs fall into that bucket. The result is wide variation: some states permit coverage with restrictions, others exclude ED drugs entirely from their preferred drug lists (PDLs).

Sildenafil was approved by the FDA for erectile dysfunction in 1998 under the brand name Viagra. The FDA approval record is publicly searchable. When Pfizer's patent expired and generic sildenafil entered the U.S. Market in 2017, the price dropped sharply, and some Medicaid managed care organizations (MCOs) added it to formulary under tight utilization management rules.

The Federal Framework for Optional Drug Categories

Under 42 CFR § 440.120, states may choose which optional benefits to include in their Medicaid programs. ED medications are classified as optional. A 2003 federal guidance memo from CMS specifically discouraged Medicaid coverage of "lifestyle drugs," a category that historically included Viagra. That designation remains influential in how state PDL committees treat sildenafil for ED, even though the same molecule in a lower dose (20 mg, brand name Revatio) is a covered drug for pulmonary arterial hypertension across nearly all state Medicaid programs. CMS Medicaid drug coverage policy is detailed at cms.gov.

Why the Same Drug Can Be Covered for One Condition but Not Another

Sildenafil 20 mg (Revatio) is FDA-approved for pulmonary arterial hypertension (PAH) [1] and sits on most Molina formularies as a covered benefit. Sildenafil 25, 50, and 100 mg tablets for ED are a different story. Coverage depends entirely on the indication listed on the prescription and the plan's formulary tier. A physician prescribing sildenafil for PAH uses a different NDC billing pathway than one prescribing it for ED, and payers adjudicate them differently.

This distinction matters practically: a member with documented PAH will typically have sildenafil covered by Molina without the same barriers faced by someone seeking it for erectile dysfunction.

Molina Healthcare's Formulary Rules for Sildenafil by Plan Type

Molina Healthcare operates across three product lines: Medicaid managed care, Medicare Advantage, and Marketplace (ACA) plans. Coverage rules differ substantially across all three.

Medicaid Managed Care Plans

Most Molina Medicaid formularies list generic sildenafil as "non-covered" or "non-formulary" for the ED indication. A minority of Molina state Medicaid contracts, particularly in states with more permissive PDLs, place generic sildenafil on a restricted tier requiring prior authorization (PA).

For PA approval in states that do allow it, Molina typically requires:

• A diagnosis of organic erectile dysfunction (ICD-10 code N52.xx series) [2]
• Documentation that the condition has a physiologic cause (vascular, neurogenic, or endocrine)
• A prescriber attestation that the drug is medically necessary
• A 30-day supply limit per authorization cycle in most plans

Brand-name Viagra is almost universally excluded under Medicaid MCO formularies, including Molina, because generic sildenafil is therapeutically equivalent and costs a fraction of the price. Prescribers requesting brand Viagra for ED face near-certain denial.

Medicare Advantage Plans (Molina Dual-Eligible and DSNP Products)

Medicare Part D plans are explicitly prohibited by statute from covering drugs used for "sexual or erectile dysfunction" as primary indications. 42 U.S.C. § 1395w-102(e)(2)(A) enumerates excluded drug classes. This means Molina's Medicare Advantage and Dual Special Needs Plans (DSNPs) will not cover sildenafil or tadalafil for ED regardless of medical necessity documentation.

Medicare Part D will cover sildenafil if it is prescribed specifically for PAH (Revatio formulation), but that coverage does not extend to off-label or ED dosing under the same Part D plan.

Marketplace (ACA) Plans

Molina's Marketplace plans are regulated by state insurance departments and ACA benchmark plan requirements. The ACA does not mandate ED drug coverage as an essential health benefit. The essential health benefits framework is described by CMS here. Some Molina Marketplace silver and gold tier plans do include generic sildenafil on a non-preferred formulary tier (typically Tier 3 or Tier 4), usually with a higher copay and a PA requirement.

Members on Marketplace plans should pull their current Summary of Benefits and Coverage (SBC) and check the plan's drug formulary directly through Molina's online portal or call member services at the number on the back of the insurance card, because formularies change annually on January 1.

Prior Authorization: What Molina Requires and How to Submit

Prior authorization is the single biggest barrier to accessing sildenafil under Molina plans that technically list it as covered. Understanding the PA process reduces delays.

Documentation Checklist

A PA request for sildenafil (ED indication) submitted to Molina should include:

• Patient demographics and Molina member ID
• Prescriber NPI and practice contact information
• Specific ICD-10 diagnosis code (example: N52.01 for erectile dysfunction due to arterial insufficiency)
• Clinical notes documenting the organic etiology of ED (vascular workup, testosterone level, HbA1c if diabetic)
• Quantity requested and days' supply
• A signed letter of medical necessity if the plan requires it

Molina must respond to standard PA requests within 14 calendar days under federal Medicaid timelines, or within 72 hours for urgent/expedited requests. CMS managed care final rule timelines are codified at 42 CFR § 438.210.

Common Reasons for PA Denial

The most frequent denial reasons for sildenafil PA requests under Medicaid MCOs are:

1. The plan excludes ED drugs from coverage entirely (no PA pathway exists).
2. Diagnosis is coded as psychogenic ED (N52.21) rather than organic ED.
3. Insufficient clinical documentation of an organic etiology.
4. The prescriber failed to attach required supporting labs or notes.
5. The request is for brand Viagra rather than generic sildenafil.

If the denial is based on the plan's categorical exclusion of ED drugs, a PA appeal will almost certainly fail on the same grounds unless new clinical information shows a covered indication (such as PAH).

How to Appeal a Molina Coverage Denial

Every Medicaid enrollee has the right to appeal a coverage denial. Appeals are governed by 42 CFR § 431.220, which guarantees a fair hearing before a state agency. The regulation text is available at the Electronic Code of Federal Regulations.

Internal Appeal First

Start with Molina's internal appeal process. Submit a written appeal within the timeframe listed in the denial notice (commonly 60 days from the denial date). Include:

• The original PA request and denial letter
• A detailed letter of medical necessity from the prescribing physician
• Any peer-reviewed evidence supporting the clinical need (see below)
• Lab results documenting the organic cause of ED (testosterone panel, lipid panel, fasting glucose, or penile Doppler if available)

Erectile dysfunction has recognized organic etiologies tied to cardiovascular risk. The Massachusetts Male Aging Study followed 1,709 men over 8.8 years and found that the age-adjusted probability of complete ED was 15% in men with treated heart disease compared with 9.6% in men without cardiovascular disease [3]. That kind of documentation strengthens the case that ED is not simply a "lifestyle" concern.

State Fair Hearing

If the internal appeal is denied, request a state fair hearing. In Medicaid, this is a legal proceeding conducted by the state Medicaid agency (not Molina), and an administrative law judge or hearing officer presides. Members can represent themselves or bring an advocate. State fair hearing rights under Medicaid are described at 42 CFR § 431.205.

Win rates at state fair hearings vary, but cases in which a physician documents an organic, physiologically based condition that happens to manifest as ED have a stronger foundation than cases based solely on quality-of-life arguments.

The Clinical Case for Treating Erectile Dysfunction

Erectile dysfunction is not a trivial condition. Clinicians increasingly treat it as a vascular biomarker. A meta-analysis published in the Journal of the American College of Cardiology (N=36,744 men) found that ED is associated with a 44% increased risk of major adverse cardiovascular events, independent of traditional risk factors [4]. This framing, ED as a cardiovascular sentinel, can inform the language in a medical necessity letter.

PDE5 Inhibitors: Mechanism and Evidence

Sildenafil inhibits phosphodiesterase type 5, preventing the degradation of cyclic guanosine monophosphate (cGMP) in smooth muscle cells. This prolongs vasodilation in the corpus cavernosum and facilitates erection in response to sexual stimulation. The pharmacology is reviewed in detail at NCBI Bookshelf.

The key Phase III trials leading to FDA approval showed that sildenafil 50 mg and 100 mg produced successful intercourse in 56% and 63% of attempts, respectively, compared with 25% for placebo (P<0.001) [5]. Response rates were lower in men with diabetes or after radical prostatectomy but remained statistically significant.

Four PDE5 inhibitors are currently FDA-approved for ED in the United States:

| Drug | Brand | Usual ED Dose | Onset | Duration | |------|-------|--------------|-------|----------| | Sildenafil | Viagra | 50 mg | 30 to 60 min | 4 to 6 hr | | Tadalafil | Cialis | 10 to 20 mg | 30 to 45 min | Up to 36 hr | | Vardenafil | Levitra | 10 mg | 25 to 60 min | 4 to 5 hr | | Avanafil | Stendra | 100 mg | 15 to 30 min | 6 hr |

Generic sildenafil is by far the most affordable option. GoodRx data consistently places 10 tablets of generic sildenafil 100 mg at $15, $30 at major pharmacy chains, making it accessible even when insurance does not cover it.

Safety Considerations

PDE5 inhibitors are contraindicated with nitrate medications (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) due to the risk of severe hypotension. The FDA prescribing information for sildenafil details this interaction. Men taking alpha-blockers (tamsulosin, doxazosin) should use caution and typically start at the lowest sildenafil dose (25 mg).

The American Urological Association (AUA) 2018 guideline on erectile dysfunction states: "Phosphodiesterase type 5 inhibitors are recommended as first-line therapy for erectile dysfunction in the absence of contraindications." [6] That guideline-level endorsement is directly quotable in a PA letter or appeal.

Alternatives When Molina Does Not Cover Sildenafil

When coverage is denied and the out-of-pocket cost of sildenafil is still a concern, several options exist.

Generic Sildenafil Out of Pocket

Since generic sildenafil entered the market, cash prices have fallen dramatically. With discount cards (GoodRx, RxSaver, Cost Plus Drugs), 6 tablets of sildenafil 100 mg can cost less than $15 at many pharmacies. For many Molina Medicaid members who pay $0 or low copays for covered drugs, this is a reasonable workaround for a drug that costs pennies to manufacture.

Mark Cuban's Cost Plus Drugs platform lists generic sildenafil 100 mg at approximately $0.44 per tablet as of early 2025, making the annual cost of one tablet per week roughly $23 before any pharmacy dispensing fee. Cost Plus Drug pricing is viewable at costplusdrugs.com.

Tadalafil (Generic Cialis)

Generic tadalafil became available in the U.S. In 2018. It carries the same PDE5 mechanism but with a longer half-life (17.5 hours vs. 3 to 5 hours for sildenafil). Tadalafil pharmacokinetics are reviewed at NCBI Bookshelf. Some Molina state formularies that exclude sildenafil for ED also exclude tadalafil, so members should verify before requesting a prescription.

Addressing Underlying Causes

Many cases of ED have modifiable contributors: obesity, type 2 diabetes, hypertension, hypogonadism, and depression. The STEP-1 trial (N=1,961) demonstrated that semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks versus 2.4% with placebo [7], and weight loss of 10% or more is associated with clinically meaningful improvement in erectile function scores. Obesity and ED are reviewed in the International Journal of Obesity literature via PubMed.

Testosterone replacement therapy (TRT) may improve ED in men with documented hypogonadism (total testosterone <300 ng/dL by two morning measurements). The Endocrine Society 2018 Clinical Practice Guideline on testosterone therapy states that testosterone therapy is appropriate for men with symptomatic hypogonadism confirmed by biochemical testing. TRT is often covered by Molina when hypogonadism is documented.

Vacuum Erection Devices and Penile Injections

Vacuum erection devices (VEDs) are durable medical equipment and may be covered under Molina's DME benefit. Intracavernosal injection therapy with alprostadil (Caverject, Edex) or trimix (a compounded combination of alprostadil, papaverine, and phentolamine) represents second-line therapy. Alprostadil injection carries an FDA approval for ED [8] and may be coverable as a medical benefit rather than a pharmacy benefit, potentially bypassing formulary exclusions.

State-by-State Variation in Molina Medicaid ED Coverage

Molina operates Medicaid MCO contracts in approximately 19 states. Because each state sets its own PDL, coverage for sildenafil for ED is not uniform across Molina plans. States like California (Medi-Cal) and New York historically have more expansive optional benefit coverage, while other states categorically exclude lifestyle drug categories.

The only authoritative way to determine your specific plan's coverage is to:

1. Call the member services number on the back of your Molina ID card.
2. Ask the representative to check your plan's formulary for "sildenafil" under the ED indication (ICD-10 N52.xx), not the PAH indication.
3. Request a written copy of the coverage determination or the formulary page in writing.
4. If covered with PA, ask for the PA criteria document (sometimes called the clinical criteria or utilization management criteria).

Molina Healthcare's member portal provides formulary look-up tools at molinahealthcare.com.

What Physicians Should Know When Writing the Prescription

A prescription that maximizes the chance of coverage approval under Molina should include:

• The specific ICD-10 code for organic ED (N52.01 arterial, N52.02 venous, N52.03 combined, N52.1 due to diseases classified elsewhere, or N52.31 erectile dysfunction following radical prostatectomy). ICD-10-CM codes for ED are searchable at the CDC ICD-10 browser.
• Generic sildenafil rather than brand Viagra.
• A supporting note in the PA submission documenting cardiovascular risk factors, hormone levels, or other objective findings.
• Awareness that some Molina plans accept electronic PA submissions through CoverMyMeds or Surescripts; others require fax.

The American College of Physicians has noted that ED in middle-aged men is increasingly recognized as a harbinger of cardiovascular disease, and that treating it may have benefits beyond quality of life. Relevant clinical guidance is available through the Annals of Internal Medicine. Framing the request in this cardiovascular context strengthens the clinical narrative.

Understanding Your Explanation of Benefits After a Claim

After a pharmacy claim for sildenafil is adjudicated (approved or denied), Molina will generate an Explanation of Benefits (EOB). Denial codes to watch for:

• Denial code 96: Non-covered charge (the drug is categorically excluded).
• Denial code 197: PA required; no valid PA on file.
• Denial code 11: PA denied.

Code 197 is the most actionable: it means coverage is possible but PA was not obtained. Resubmit with a complete PA. Code 96 means the plan excludes the drug, and the path forward is either a state fair hearing, a switch to an alternative therapy, or cash pay.